July 12, 2022
Cologne, Germany -- Maleth Program is the first space bioscience project led by Professor Joseph Borg of the University of Malta. The second mission under the Maleth Program, or Maleth II,was launched on the July 15th, 2022. "Maleth II boarded a SpaceX Dragon Spacecraft for the launch as part of Commercial Re-supply mission 25 (CRS25) [...]
Discovery Life Sciences Acquires AllCells
July 12, 2022
Creates Premier Global Provider of Critical Starting Materials and Analytic Services to Accelerate Cell and Gene Therapy Applications HUNTSVILLE, Ala. & ALAMEDA, Calif. --Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced its acquisition of AllCells® , a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products. With more than 30 [...]
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring
July 12, 2022
Highly Selective Recombinant Monoclonal Antibodies Targeting Brentuximab Vedotin, Secukinumab, and Their Biosimilars HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to brentuximab vedotin (Adcetris), secukinumab (Cosentyx), and [...]
July 12, 2022
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced that ProteinSimple, a Bio-Techne brand, has launched the innovative Maurice™ Turbo CE-SDS cartridge. As the name suggests, Turbo enables high speed and high resolution analysis of protein size and purity on Maurice, the flagship capillary electrophoresis (CE) instrument of the iCE family. By providing protein purity results in as few [...]
Molecular LIMS Leader Launches Ovation Research Network
July 12, 2022
The Ovation Research Network is the latest addition to the NIH’s RADx Tech Variant Task Force, providing near-immediate tracking of SARS-CoV-2 variants CAMBRIDGE, Mass. -- Cloud-based molecular Laboratory Information Management Software (LIMS) leader Ovation today announced the formal launch of the Ovation Research Network. The Ovation Research Network is a platform of clinical laboratories who use Ovation’s [...]
BioFlyte Welcomes New CEO to Drive Commercialization Efforts
July 12, 2022
Following its Series A financing, BioFlyte welcomes national security and public safety executive Todd Sickles as CEO to accelerate productization and market penetration of its disruptive biodetection technology ALBUQUERQUE, N.M. -- BioFlyte, a bioaerosol surveillance firm with a disruptive new class of fieldable biological threat collection, detection, and identification solutions, today announced that experienced and [...]
July 12, 2022
Fast, flexible and easy-to-use qScript Ultra Flex Kit and qScript Ultra SuperMix enable scientists to reverse transcribe longer targets and maximize yields from challenging samples in only 10 minutes BEVERLY, Mass. – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced [...]
July 12, 2022
NEWARK, Calif. — Ultima Genomics, Inc. (the Company) has signed an agreement with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) to further advance Ultima Genomics' sequencing architecture. Under the terms of the agreement, Regeneron will collaborate with Ultima on the development and testing of Ultima's second-generation sequencing platform, which will build upon the advances of the Company's first [...]
Unchained Labs likes it hot, launches new isothermal applications on Uncle!
July 12, 2022
Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched new isothermal applications for biologics and gene therapies on its Uncle platform today. Uncle is the gold standard for measuring protein and AAV stability and with these new applications, it’s hands down [...]
July 12, 2022
WAYNE, Pa. -- Argosy Healthcare Partners ("AHP"), a lower middle market private equity investor focused exclusively on healthcare, and a division of Argosy Capital, a diversified investment firm with $2.7 billion in assets under management, is pleased to announce that it completed the recapitalization and merger of Hudson Robotics ("HR") and Art Robbins Instruments ("ARI" and, together with HR, [...]

